JAZZ
Jazz Pharmaceuticals
$251.88
▼ -0.39%
−$0.98
NYSE · Healthcare · Biotechnology
· price updated 9h ago
Jazz Pharmaceuticals
JAZZ · NYSE · Healthcare · Biotechnology · price updated 9h ago
$251.88
▼ -0.39% · −$0.98 today
AI research · $251.88
Track JAZZ for continuous AI research
price position
Where JAZZ sits now
52-week range
Low$105.00
High$261.30
Today $251.88
RSI (14)
65.1Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$2.9B
Total debt$5.4B
Net cash after debt$-2.5B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 50% below Sector avg · favorable
10.28x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
3.58x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
12.51x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
27.29x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
18.0%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
0.7%
Debt / equity
Balance-sheet leverage
Middle ground · Lagging most sector peers
1.20x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.04x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How JAZZ compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $15.88B | 2559.7 | +9.2% | 59 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
activity
What is moving JAZZ
US stock research
About Jazz Pharmaceuticals (JAZZ) stock
Jazz Pharmaceuticals tracked in the US core universe. JAZZ was -0.4% in the latest available session at $251.88. Its reported market value was $15.88B with a trailing P/E of 2559.7. Latest reported revenue was $4.44B, changing +9.2% year over year, with $29.49M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $251.88
- Day change
- -0.4%
- Market cap
- $15.88B
- P/E (TTM)
- 2559.7
- Revenue growth
- +9.2%
- Industry
- Biotechnology